Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
61.93
-1.97 (-3.08%)
At close: May 15, 2026, 4:00 PM EDT
61.74
-0.19 (-0.31%)
After-hours: May 15, 2026, 7:43 PM EDT
Oruka Therapeutics Employees
Oruka Therapeutics had 68 employees as of December 31, 2025. The number of employees increased by 40 or 142.86% compared to the previous year.
Employees
68
Change (1Y)
40
Growth (1Y)
142.86%
Revenue / Employee
n/a
Profits / Employee
-$1,385,147
Market Cap
3.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | 40 | 142.86% |
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Travere Therapeutics | 497 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
| Tango Therapeutics | 137 |
ORKA News
- 3 days ago - Oruka Therapeutics reports Q1 EPS (48c), consensus (54c) - TheFly
- 3 days ago - Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 days ago - Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis - TheFly
- 10 days ago - Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology - PRNewsWire
- 16 days ago - Oruka Therapeutics price target raised to $120 from $109 at Leerink - TheFly
- 17 days ago - Oruka Therapeutics price target raised to $120 from $75 at H.C. Wainwright - TheFly
- 18 days ago - Oruka Therapeutics $700M Secondary priced at $72.50 - TheFly
- 18 days ago - Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering - GlobeNewsWire